Blog

Type

Issue

Tag

Why more mammograms aren’t the solution to breast cancer

A recent analysis by the Lown Institute, a nonprofit health care think tank, highlighted some key USPSTF figures that show the limits of mammograms in a helpful way. The analysis imagines a world without screening mammograms, in which women seek evaluation for breast cancer only when they notice a breast lump or other concerning symptoms. According to the USPSTF’s models, about 28 out of every 1,000 women in this world would die from breast cancer at some point in their lives.

More

Imagining the future of quality in medicine: Dr. Vikas Saini honored with Avedis Donabedian International Award

Last week, Lown president Dr. Vikas Saini was presented with the Donabedian International Award. In his acceptance remarks, Dr. Saini shared his vision for a future of medicine that uses new technologies for socially responsible goals, while still keeping empathy and the human connection in medicine at the forefront. More

Balancing prevention and overdiagnosis in skin cancer screening

A recent editorial published in JAMA Dermatology discussed the balance between prevention and overdiagnosis of skin cancer. This comes in response to the U.S. Preventive Services Task Force concluding for the fourth time in a row that visual skin cancer screening has insufficient evidence to support its population-wide benefit. How do we know when we’ve crossed from prevention to overuse, and is there anything we can do to keep the balance? More

Too many people take too many pills

“Polypharmacy”, as doctors call it, imposes a big drag on health. A recent study at a hospital in Liverpool found that nearly one in five hospital admissions was caused by adverse reactions to drugs. The Lown Institute, an American think-tank, reckons that, between 2020 and 2030, medication overload in America could cause more than 150,000 premature deaths and 4.5m hospital admissions. More